Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma

Cellular Physiology and Biochemistry

Volumn 30, Issue 6, 2012, Pages 1481-1490

  Li, Guodong ^a   Cai, Ming ^a   Fu, Dong ^a   Chen, Kai ^a   Sun, Mengxiong ^a   Cai, Zhengdong ^a   Cheng, Biao ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Akt; Apoptosis; HSP90B1; MiR 223; MTOR; Osteosarcoma; PI3K

Indexed keywords

CD34 ANTIGEN; COMPLEMENTARY DNA; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90B1; MICRORNA 223; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BID; PROTEIN KINASE B; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; MICROVASCULATURE; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 84870299410     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343336     Document Type: Article

References (39)

1. Enneking WF: Editorial: Osteosarcoma. Clin Orthop Relat Res 1975:2-4.
2. Brooks S, Starkie CM, Clarke NM: Osteosarcoma after the fourth decade. A clinico-pathological review. Arch Orthop Trauma Surg 1985;104:100-105. (Pubitemid 15233337)
3. Kozakewich H, Perez-Atayde AR, Goorin AM, Wilkinson RH, Gebhardt MC, Vawter GF: Osteosarcoma in young children. Cancer 1991;67:638-642.
4. Welch WJ, Feramisco JR: Purification of the major mammalian heat shock proteins. J Biol Chem 1982;257:14949-14959.
5. Crevel G, Bates H, Huikeshoven H, Cotterill S: The drosophila dpit47 protein is a nuclear hsp90 co-chaperone that interacts with DNA polymerase alpha. J Cell Sci 2001;114:2015-2025.
6. Jia W, Yu C, Rahmani M, Krystal G, Sausville EA, Dent P, Grant S: Synergistic antileukemic interactions between 17-aag and ucn-01 involve interruption of raf/mek-and akt-related pathways. Blood 2003;102:1824-1832. (Pubitemid 37022579)
7. Neri LM, Borgatti P, Capitani S, Martelli AM: The nuclear phosphoinositide 3-kinase/akt pathway: A new second messenger system. Biochim Biophys Acta 2002;1584:73-80. (Pubitemid 35217879)
8. Williams CR, Tabios R, Linehan WM, Neckers L: Intratumor injection of the hsp90 inhibitor 17aag decreases tumor growth and induces apoptosis in a prostate cancer xenograft model. J Urol 2007;178:1528-1532. (Pubitemid 47376711)
9. Vanaja DK, Mitchell SH, Toft DO, Young CY: Effect of geldanamycin on androgen receptor function and stability. Cell Stress Chaperones 2002;7:55-64. (Pubitemid 36138904)
10. Flandrin P, Guyotat D, Duval A, Cornillon J, Tavernier E, Nadal N, Campos L: Significance of heat-shock protein (hsp) 90 expression in acute myeloid leukemia cells. Cell Stress Chaperones 2008;13:357-364.
11. Senju M, Sueoka N, Sato A, Iwanaga K, Sakao Y, Tomimitsu S, Tominaga M, Irie K, Hayashi S, Sueoka E: Hsp90 inhibitors cause g2/m arrest associated with the reduction of cdc25c and cdc2 in lung cancer cell lines. J Cancer Res Clin Oncol 2006;132:150-158. (Pubitemid 43015775)
12. Graham G, Sharp PJ, Li Q, Wilson PW, Talbot RT, Downing A, Boswell T: Hsp90b1, a thyroid hormone-responsive heat shock protein gene involved in photoperiodic signaling. Brain Res Bull 2009;79:201-207.
13. Li Z: Glucose regulated protein 78: A critical link between tumor microenvironment and cancer hallmarks. Biochim Biophys Acta 2012;1826:13-22.
14. Krishnamoorthy S, Honn KV: Eicosanoids and other lipid mediators and the tumor hypoxic microenvironment. Cancer Metastasis Rev 2011;30:613-618.
15. Ryder C, McColl K, Zhong F, Distelhorst CW: Acidosis promotes bcl-2 family-mediated evasion of apoptosis: Involvement of acid-sensing g protein-coupled receptor gpr65 signaling to mek/erk. J Biol Chem 2012;287:27863-27875.
16. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Gomella LG, Croce CM, Baffa R: Micro-rna profiling in kidney and bladder cancers. Urologic oncology 2007;25:387-392. (Pubitemid 47362758)
17. Kobayashi E, Hornicek FJ, Duan Z: Microrna involvement in osteosarcoma. Sarcoma 2012;2012:359739.
18. Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, Le Blanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Aqeilan RI: Mirna signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 2012;72:1865-1877.
19. Lulla RR, Costa FF, Bischof JM, Chou PM, De F B M, Vanin EF, Soares MB: Identification of differentially expressed micrornas in osteosarcoma. Sarcoma 2011;2011:732690.
20. Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L: Microrna-21 is involved in osteosarcoma cell invasion and migration. Med Oncol 2011;28:1469-1474.
21. Lulla RR, Costa FF, Bischof JM, Chou PM, De F B M, Vanin EF, Soares MB: Identification of differentially expressed micrornas in osteosarcoma. Sarcoma 2011;2011:732690.
22. Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, D'Arcy T, McGuinness E, Sheils O, Sheppard B, J OL: Potential role of mir-9 and mir-223 in recurrent ovarian cancer. Molecular cancer 2008;7:35.
23. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X: Plasma micrornas are promising novel biomarkers for early detection of colorectal cancer. International journal of cancer Journal international du cancer 2010;127:118-126.
24. Ritossa F: Discovery of the heat shock response. Cell Stress Chaperones 1996;1:97-98.
25. Ritossa P: [problems of prophylactic vaccinations of infants]. Riv Ist Sieroter Ital 1962;37:79-108.
26. Isaacs JS, Xu W, Neckers L: Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 2003;3:213-217. (Pubitemid 37443877)
27. Mahindra A, Cirstea D, Raje N: Novel therapeutic targets for multiple myeloma. Future Oncol 2010;6:407-418.
28. Takayama S, Reed JC, Homma S: Heat-shock proteins as regulators of apoptosis. Oncogene 2003;22:9041-9047. (Pubitemid 38121704)
29. Moon A, Bacchini P, Bertoni F, Olvi LG, Santini-Araujo E, Kim YW, Park YK: Expression of heat shock proteins in osteosarcomas. Pathology 2010;42:421-425.
30. Bader AG, Kang S, Zhao L, Vogt PK: Oncogenic pi3k deregulates transcription and translation. Nat Rev Cancer 2005;5:921-929. (Pubitemid 41766781)
31. Engelman JA, Luo J, Cantley LC: The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006;7:606-619. (Pubitemid 44100518)
32. Vivanco I, Sawyers CL: The phosphatidylinositol 3-kinase akt pathway in human cancer. Nat Rev Cancer 2002;2:489-501. (Pubitemid 37328931)
33. Wu Z, Min L, Chen D, Hao D, Duan Y, Qiu G, Wang Y: Overexpression of bmi-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma. PLoS One 2011;6:e14648.
34. Sieghart W, Fuereder T, Schmid K, Cejka D, Werzowa J, Wrba F, Wang X, Gruber D, Rasoul-Rockenschaub S, Peck-Radosavljevic M, Wacheck V: Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation. Transplantation 2007;83:425-432. (Pubitemid 46667846)
35. Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, Tovar V, Roayaie S, Minguez B, Sole M, Battiston C, Van Laarhoven S, Fiel MI, Di Feo A, Hoshida Y, Yea S, Toffanin S, Ramos A, Martignetti JA, Mazzaferro V, Bruix J, Waxman S, Schwartz M, Meyerson M, Friedman SL, Llovet JM: Pivotal role of mtor signaling in hepatocellular carcinoma. Gastroenterology 2008;135:1972-1983, 1983 e1-11.
36. Zhou L, Huang Y, Li J, Wang Z: The mtor pathway is associated with the poor prognosis of human hepatocellular carcinoma. Med Oncol 2010;27:255-261.
37. Brognard J, Clark AS, Ni Y, Dennis PA: Akt/protein kinase b is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 2001;61:3986-3997. (Pubitemid 32720961)
38. Huang WC, Hung MC: Induction of akt activity by chemotherapy confers acquired resistance. J Formos Med Assoc 2009;108:180-194.
39. Sato S, Fujita N, Tsuruo T: Modulation of akt kinase activity by binding to hsp90. Proc Natl Acad Sci USA 2000;97:10832-10837.